https://lsstrategysummit.com/agenda2026-08-11T17:46:59Zhttps://lsstrategysummit.com/agenda/registration-networking-breakfast-12026-08-11T17:43:51Zhttps://lsstrategysummit.com/agenda/expanded-bolar-exemption-safe-harbor-race-market-strategic-implications-originators-generics2026-08-12T21:01:30Zhttps://lsstrategysummit.com/agenda/co-chair-opening-remarks-introduction2026-08-11T17:43:51Zhttps://lsstrategysummit.com/agenda/core-challenges-life-sciences-1-new-eu-life-sciences-legislation-cross-practice-perspectives-eu-pharma-package-biotech-act2026-08-12T21:01:15Zhttps://lsstrategysummit.com/agenda/networking-break-32026-08-11T17:43:51Zhttps://lsstrategysummit.com/agenda/quick-fire-presentation-managing-career-progression-establishing-influence-leading-effective-teams-life-science-legal-sector2026-08-12T21:02:32Zhttps://lsstrategysummit.com/agenda/networking-lunch-12026-08-11T17:43:51Zhttps://lsstrategysummit.com/agenda/leading-ai-strategy-eu-ai-act-rise-high-risk-ai-systems-life-science-value-chain2026-08-12T21:03:03Zhttps://lsstrategysummit.com/agenda/regulatory-protection-transition-understanding-evolving-rdp-market-exclusivity-frameworks-europe-us2026-08-12T21:02:47Zhttps://lsstrategysummit.com/agenda/pricing-reimbursement-market-access-transition-rethinking-commercial-strategy-europes-new-regulatory-framework2026-08-12T21:02:14Zhttps://lsstrategysummit.com/agenda/co-ordinating-publication-protection-balancing-patent-strategies-against-clinical-trial-disclosures2026-08-12T21:04:04Zhttps://lsstrategysummit.com/agenda/10-minute-track-switchover-break2026-08-11T17:43:51Zhttps://lsstrategysummit.com/agenda/readthrough-turning-global-ip-disputes-european-advantage2026-08-12T21:05:07Zhttps://lsstrategysummit.com/agenda/core-challenges-life-sciences-2-geopolitics-reshaping-legal-strategy-deal-making-global-life-sciences-sector2026-08-12T21:03:50Zhttps://lsstrategysummit.com/agenda/harnessing-regulation-competitive-lever-strategy-intersection-market-access-pricing-antitrust-exposure2026-08-12T21:04:39Zhttps://lsstrategysummit.com/agenda/managing-class-action-exposure-litigation-risk-under-new-eu-product-liability-reform2026-08-12T21:05:25Zhttps://lsstrategysummit.com/agenda/interactive-workshop-building-strategic-influence-women-life-sciences-legal-leadership2026-08-12T21:05:53Zhttps://lsstrategysummit.com/agenda/securing-robust-antibody-ip-portfolios-europe-us-enablement-obviousness-strategies-maximising-protection-scope2026-08-12T21:05:39Zhttps://lsstrategysummit.com/agenda/spc-manufacturing-waiver-strategic-implications-originators-market-entrants2026-08-12T21:06:10Zhttps://lsstrategysummit.com/agenda/evolving-global-ip-regulatory-landscape-latin-america-apac2026-08-12T21:06:27Zhttps://lsstrategysummit.com/agenda/networking-break-22026-08-11T17:43:51Zhttps://lsstrategysummit.com/agenda/successfully-navigate-new-discretionary-denial-standards-us-patent-trial-appeal-board2026-08-12T21:06:45Zhttps://lsstrategysummit.com/agenda/doctrine-equivalents-pan-european-injunctions-aflibercept2026-08-12T21:07:07Zhttps://lsstrategysummit.com/agenda/managing-ip-ownership-transfers-portfolio-transitions-cross-border-deals2026-08-12T21:07:32Zhttps://lsstrategysummit.com/agenda/inside-us-product-liability-litigation-strategy-era-mass-claims2026-08-12T21:07:58Zhttps://lsstrategysummit.com/agenda/beyond-patents-management-strategic-role-trade-secrets-life-sciences2026-08-12T21:08:23Zhttps://lsstrategysummit.com/agenda/eu-mdr-ivdr-recent-amendments-practical-consequences2026-08-12T21:08:41Zhttps://lsstrategysummit.com/agenda/wastewater-beyond-managing-esg-risk-changing-eu-framework2026-08-12T21:08:59Zhttps://lsstrategysummit.com/agenda/joint-advocacy-competition-risk-life-sciences-regulatory-engagement2026-08-12T21:09:19Zhttps://lsstrategysummit.com/agenda/managing-clean-room-risk-mitigation-information-governance-strategic-control2026-08-12T21:09:42Zhttps://lsstrategysummit.com/agenda/life-science-legal-leadership-roundtable2026-08-12T21:10:00Zhttps://lsstrategysummit.com/agenda/day-1-networking-drinks-reception2026-08-11T17:43:51Zhttps://lsstrategysummit.com/agenda/registration-networking-breakfast2026-08-11T17:43:51Zhttps://lsstrategysummit.com/agenda/managing-cre-cde-best-effort-obligations-life-science-transactions2026-08-12T21:10:25Zhttps://lsstrategysummit.com/agenda/scaling-through-transactions-legal-strategy-life-science-smes2026-08-12T21:10:44Zhttps://lsstrategysummit.com/agenda/ai-legal-tools-life-sciences-experimentation-integration2026-08-12T21:11:11Zhttps://lsstrategysummit.com/agenda/convergence-divergence-side-side-comparison-patentability-standards-epo-upc2026-08-12T21:11:28Zhttps://lsstrategysummit.com/agenda/co-chair-opening-remarks-recap-day-12026-08-11T17:43:51Zhttps://lsstrategysummit.com/agenda/networking-break-12026-08-11T17:43:51Zhttps://lsstrategysummit.com/agenda/life-science-antitrust-insights-european-commission2026-08-12T21:12:07Zhttps://lsstrategysummit.com/agenda/life-science-gc-clo-invitation-briefing2026-08-11T20:48:40Zhttps://lsstrategysummit.com/agenda/core-challenges-life-sciences-3-antitrust-crucial-cross-practice-issue2026-08-12T21:12:31Zhttps://lsstrategysummit.com/agenda/china-focus-ip-regulatory-landscape-evolving-compare-situation-europe2026-08-12T21:12:51Zhttps://lsstrategysummit.com/agenda/quick-fire-presentation-fampridine-decisions-fcj-german-epo-decisions-evaluating-patentability-view-clinical-trials-prior-art2026-08-12T21:13:31Zhttps://lsstrategysummit.com/agenda/governance-implementation-market-impact-strategic-business-implications-critical-medicines-act2026-08-12T21:13:46Zhttps://lsstrategysummit.com/agenda/networking-lunch2026-08-11T17:43:51Zhttps://lsstrategysummit.com/agenda/evolving-spc-framework-cjeu-case-law-national-divergence-patent-office-perspectives2026-08-12T21:14:23Zhttps://lsstrategysummit.com/agenda/product-communications-competition-risk-life-sciences-navigating-boundary-between-legitimate-debate-disparagement2026-08-12T21:14:40Zhttps://lsstrategysummit.com/agenda/authorisation-obligation-navigating-eu-launch-supply-mandates-global-pricing-access-landscape2026-08-12T21:13:08Zhttps://lsstrategysummit.com/agenda/black-box-innovation-building-robust-ip-regulatory-strategies-ai-discovered-therapeutics2026-08-12T21:14:05Zhttps://lsstrategysummit.com/agenda/second-medical-use-skinny-labelling-building-robust-ip-exclusivity-strategy2026-08-12T21:17:33Zhttps://lsstrategysummit.com/agenda/designing-disputing-divisional-portfolios-new-insights-interface-between-ip-antitrust2026-08-12T21:18:09Zhttps://lsstrategysummit.com/agenda/securing-value-life-sciences-acquisitions-managing-foreign-investment-clearance-ip-risk2026-08-12T21:18:24Zhttps://lsstrategysummit.com/agenda/building-international-presence-core-legal-business-considerations-life-science-companies-moving-new-markets2026-08-12T21:17:45Zhttps://lsstrategysummit.com/agenda/quick-fire-presentation-delegate-routine-judgement-framework-ai-agents-legal-team2026-08-12T21:17:17Zhttps://lsstrategysummit.com/agenda/diverging-life-science-patent-standards-contrasting-european-uspto-approaches-mean-global-ip-strategy2026-08-12T21:18:40Zhttps://lsstrategysummit.com/agenda/networking-break2026-08-11T17:43:51Zhttps://lsstrategysummit.com/agenda/structuring-life-science-m-under-scrutiny-horizontal-concentration-vertical-integration-risk2026-08-12T21:18:53Zhttps://lsstrategysummit.com/agenda/recap-day-2-chairs-conclude-event2026-08-12T21:19:04Z